51. The protective effects of Ferrostatin-1 against inflammation-induced preterm birth and fetal brain injury.
- Author
-
Chen C, Zhu S, Fu T, Chen Y, and Chen D
- Subjects
- Animals, Female, Pregnancy, Mice, Humans, Inflammation immunology, Inflammation drug therapy, Disease Models, Animal, Mice, Inbred C57BL, Premature Birth immunology, Premature Birth prevention & control, Cyclohexylamines pharmacology, Cyclohexylamines administration & dosage, Placenta pathology, Placenta immunology, Placenta drug effects, Brain Injuries prevention & control, Brain Injuries immunology, Brain Injuries etiology, Brain Injuries drug therapy, Brain Injuries pathology, Phenylenediamines pharmacology, Phenylenediamines administration & dosage, Lipopolysaccharides immunology, Ferroptosis drug effects
- Abstract
Introduction: Recent studies have suggested the involvement of ferroptosis in preterm birth. Despite compelling evidence, the underlying mechanism remains unknown. This investigation aimed to determine the therapeutic effects of Ferrostatin-1 (Fer-1), an inhibitor of ferroptosis, in preterm birth and fetal brain injury., Methods: Human placenta samples and clinical data of participants were collected to ascertain whether placental ferroptosis was associated with preterm birth. Lipopolysaccharide (LPS)-induced preterm birth mouse model was used to examine the protective effects of Fer-1 on preterm birth. Fetal brain tissues and offspring mice at 5 and 8 weeks were studied to determine the effects of Fer-1 on the cognitive function of offspring., Results: We examined the mechanism of spontaneous preterm birth and discovered that placental ferroptosis was associated with preterm birth. Fer-1 inhibited preterm birth by ameliorating placental ferroptosis and maternal inflammation, thus improving LPS-induced intrauterine inflammation to maintain pregnancy. Antenatal administration of Fer-1 prevented LPS-induced fetal brain damage in the acute phase and improved long-term neurodevelopmental impairments by improving placental neuroendocrine signaling and maintaining placental function., Conclusion: Fer-1 inhibited preterm birth and fetal brain injury by inhibiting maternal inflammation and improving placental function. Our findings provide a novel therapeutic strategy for preterm birth., Competing Interests: Declaration of Competing Interest We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF